Paid Clinical Trials in Monroe, LA
As of September 2026, 23 paid clinical trials are recruiting in Monroe, Louisiana. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Monroe offers studies at sites including Ochsner LSU Health Monroe Medical Center for conditions such as Anatomic Stage II Breast Cancer AJCC v8, Overweight, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Monroe
Trials by drug in Monroe
Filter results
Newly added in Monroe
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
23 clinical trials
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Top Research Study Locations in Monroe
Researchers run research studies in Monroe, LA at 12 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Ochsner LSU Health Monroe Medical Center | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 6 |
| Delta Research Partners | Metabolic Dysfunction-associated Steatohepatitis, Ulcerative Colitis, Crohn's Disease | 4 |
| IMA Clinical Research | Cardiovascular Disease, Diabetic Kidney Disease (DKD) | 2 |
| IMA Clinical Research Monroe - Armand | Obesity, Overweight | 2 |
| ArkLaMiss Surgery Center, LLC | Lumbar Spinal Stenosis | 1 |
| Delta Research Partners | Ulcerative Colitis | 1 |
| Epic Medical Research | Anemia, Myelodysplastic Syndrome | 1 |
| Epic Medical Research - Monroe | Extensive-stage Small Cell Lung Cancer (ES-SCLC), Small Cell Lung Cancer (SCLC) | 1 |
| IMA Clinical Research Monroe | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 1 |
| IMA Clinical Research Monroe-Main | Obesity, Abdominal, Overweight, Prediabetic State | 1 |
| Louisiana Pain Care | Lumbar Spinal Stenosis | 1 |
| Ochsner LSU Health - Monroe Medical Center, Family Medicine Clinic | Lymphoma, Large B-Cell, Diffuse | 1 |
Active & Upcoming Studies in Monroe (2026)
Recruiting trials in Monroe grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (8 active studies)
- DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy · Phase 3 · Boehringer Ingelheim
- Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors · Phase 3 · SWOG Cancer Research Network
Diabetes & metabolic (5 active studies)
- A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity · Phase 3 · Eli Lilly and Company
- A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight · Phase 3 · AstraZeneca
Cardiovascular (1 active study)
Common conditions studied in Monroe
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies)
- Overweight (3 active studies)
- Anatomic Stage I Breast Cancer AJCC v8 (2 active studies)
- Anatomic Stage IIIA Breast Cancer AJCC v8 (2 active studies)
- Anatomic Stage IIIB Breast Cancer AJCC v8 (2 active studies)
- Crohn's Disease (2 active studies)
Leading research sponsors in Monroe
- Sanofi
- Eli Lilly and Company
- Alliance for Clinical Trials in Oncology
- AstraZeneca
- Boehringer Ingelheim
Frequently asked questions
How many paid clinical trials are currently recruiting in Monroe?
There are approximately 23 recruiting clinical trials in Monroe, Louisiana listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Monroe pay participants?
Most recruiting trials in Monroe compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Monroe?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Monroe?
The most common conditions under active study in Monroe include Anatomic Stage II Breast Cancer AJCC v8 (4), Overweight (3), Anatomic Stage I Breast Cancer AJCC v8 (2), Anatomic Stage IIIA Breast Cancer AJCC v8 (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Monroe?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Monroe on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Monroe?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Monroe?
Recruiting research sites in Monroe include Ochsner LSU Health Monroe Medical Center, Delta Research Partners, IMA Clinical Research, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Monroe right now?
The largest active categories in Monroe are Cancer & tumors (8), Diabetes & metabolic (5), Cardiovascular (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.